Massachusetts Financial Services CO Lyell Immunopharma, Inc. Transaction History

Massachusetts Financial Services CO

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$1.3 - $3.01 $1.25 Million - $2.9 Million	-963,521 Reduced 62.53%	577,319 $837,000
Q1 2024 May 14, 2024	BUY	$1.71 - $3.07 $318,337 - $571,517	186,162 Added 13.74%	1,540,840 $3.44 Million
Q4 2023 Feb 08, 2024	SELL	$1.39 - $2.35 $11,831 - $20,003	-8,512 Reduced 0.62%	1,354,678 $2.63 Million
Q3 2023 Nov 08, 2023	SELL	$1.45 - $3.35 $14,540 - $33,593	-10,028 Reduced 0.73%	1,363,190 $2 Million
Q2 2023 Aug 09, 2023	SELL	$1.89 - $3.86 $34,379 - $70,213	-18,190 Reduced 1.31%	1,373,218 $4.37 Million
Q1 2023 May 10, 2023	BUY	$1.97 - $3.58 $202,675 - $368,313	102,881 Added 7.98%	1,391,408 $3.28 Million
Q4 2022 Feb 13, 2023	BUY	$2.78 - $8.09 $635,591 - $1.85 Million	228,630 Added 21.57%	1,288,527 $4.47 Million
Q3 2022 Nov 09, 2022	BUY	$5.54 - $8.27 $397,705 - $593,686	71,788 Added 7.27%	1,059,897 $7.77 Million
Q2 2022 Aug 09, 2022	SELL	$3.68 - $6.8 $27,312 - $50,469	-7,422 Reduced 0.75%	988,109 $6.44 Million
Q1 2022 May 11, 2022	BUY	$5.05 - $7.7 $138,703 - $211,488	27,466 Added 2.84%	995,531 $5.03 Million
Q4 2021 Feb 10, 2022	SELL	$7.13 - $15.19 $50,801 - $108,228	-7,125 Reduced 0.73%	968,065 $7.49 Million
Q3 2021 Nov 10, 2021	SELL	$11.0 - $17.95 $140,118 - $228,647	-12,738 Reduced 1.29%	975,190 $14.4 Million
Q2 2021 Aug 13, 2021	BUY	$15.99 - $16.89 $15.8 Million - $16.7 Million	987,928 New	987,928 $16 Million

121

142M

18.1K

200

Ticker LYEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 247,824,992
Market Cap $151M
Description
Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

Stay updated on Massachusetts Financial Services CO with notifications on news.